These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 25438283)

  • 1. Measurement of portal pressure.
    Abraldes JG; Sarlieve P; Tandon P
    Clin Liver Dis; 2014 Nov; 18(4):779-92. PubMed ID: 25438283
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as a guide for prophylaxis and therapy of bleeding and rebleeding? No.
    Thalheimer U; Bellis L; Puoti C; Burroughs AK
    Eur J Intern Med; 2011 Feb; 22(1):5-7. PubMed ID: 21238884
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Right atrial pressure is not adequate to calculate portal pressure gradient in cirrhosis: a clinical-hemodynamic correlation study.
    La Mura V; Abraldes JG; Berzigotti A; Erice E; Flores-Arroyo A; García-Pagán JC; Bosch J
    Hepatology; 2010 Jun; 51(6):2108-16. PubMed ID: 20512998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of deep sedation on the accuracy of hepatic and portal venous pressure measurements in patients with cirrhosis.
    Reverter E; Blasi A; Abraldes JG; Martínez-Palli G; Seijo S; Turon F; Berzigotti A; Balust J; Bosch J; García-Pagán JC
    Liver Int; 2014 Jan; 34(1):16-25. PubMed ID: 23763484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simvastatin lowers portal pressure in patients with cirrhosis and portal hypertension: a randomized controlled trial.
    Abraldes JG; Albillos A; Bañares R; Turnes J; González R; García-Pagán JC; Bosch J
    Gastroenterology; 2009 May; 136(5):1651-8. PubMed ID: 19208350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: the therapeutic and prognostic benefit of portal pressure reduction in cirrhosis.
    Triantos CK; Nikolopoulou V; Burroughs AK
    Aliment Pharmacol Ther; 2008 Oct; 28(8):943-52. PubMed ID: 18627364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension.
    Manolakopoulos S; Triantos C; Theodoropoulos J; Vlachogiannakos J; Kougioumtzan A; Papatheodoridis G; Tzourmakliotis D; Karamanolis D; Burroughs AK; Archimandritis A; Raptis S; Avgerinos A
    J Hepatol; 2009 Sep; 51(3):468-74. PubMed ID: 19616339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Should we routinely measure portal pressure in patients with cirrhosis, using hepatic venous pressure gradient (HVPG) as guidance for prophylaxis and treatment of bleeding and re-bleeding? Yes!
    Merkel C; Montagnese S
    Eur J Intern Med; 2011 Feb; 22(1):1-4. PubMed ID: 21238883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Are there any alternative methods to hepatic venous pressure gradient in portal hypertension assessment?
    Procopeţ B; Tantau M; Bureau C
    J Gastrointestin Liver Dis; 2013 Mar; 22(1):73-8. PubMed ID: 23539394
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute hemodynamic response to beta-blockers and prediction of long-term outcome in primary prophylaxis of variceal bleeding.
    Villanueva C; Aracil C; Colomo A; Hernández-Gea V; López-Balaguer JM; Alvarez-Urturi C; Torras X; Balanzó J; Guarner C
    Gastroenterology; 2009 Jul; 137(1):119-28. PubMed ID: 19344721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria.
    Merkel C; Bolognesi M; Berzigotti A; Amodio P; Cavasin L; Casarotto IM; Zoli M; Gatta A
    J Hepatol; 2010 Jan; 52(1):45-53. PubMed ID: 19914730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carvedilol or propranolol in portal hypertension? A randomized comparison.
    Hobolth L; Møller S; Grønbæk H; Roelsgaard K; Bendtsen F; Feldager Hansen E
    Scand J Gastroenterol; 2012 Apr; 47(4):467-74. PubMed ID: 22401315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predictive Value of Hepatic Venous Pressure Gradient for Graft Hemodynamics in Living Donor Liver Transplantation.
    Matsushima H; Fujiki M; Sasaki K; Rotroff DM; Sands M; Bayona Molano MDP; Aucejo F; Diago Uso T; Eghtesad B; Miller C; Quintini C; Hashimoto K
    Liver Transpl; 2019 Jul; 25(7):1034-1042. PubMed ID: 30980599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of acute hemodynamic response to i.v. propranolol in patients with cirrhosis and portal hypertension.
    La Mura V; Abraldes JG; Raffa S; Retto O; Berzigotti A; García-Pagán JC; Bosch J
    J Hepatol; 2009 Aug; 51(2):279-87. PubMed ID: 19501930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Portal pressure should be measured on suspicion of portal hypertension].
    Møller S; Bendtsen F
    Ugeskr Laeger; 2010 Dec; 172(49):3411-3. PubMed ID: 21129318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis.
    Ripoll C; Groszmann R; Garcia-Tsao G; Grace N; Burroughs A; Planas R; Escorsell A; Garcia-Pagan JC; Makuch R; Patch D; Matloff DS; Bosch J;
    Gastroenterology; 2007 Aug; 133(2):481-8. PubMed ID: 17681169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A randomized trial to assess whether portal pressure guided therapy to prevent variceal rebleeding improves survival in cirrhosis.
    Villanueva C; Graupera I; Aracil C; Alvarado E; Miñana J; Puente Á; Hernandez-Gea V; Ardevol A; Pavel O; Colomo A; Concepción M; Poca M; Torras X; Reñe JM; Guarner C
    Hepatology; 2017 May; 65(5):1693-1707. PubMed ID: 28100019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of propranolol response by catheterization and Doppler ultrasonography in patients with cirrhosis].
    Castaño G; Viudez P; Carlevaro O; Ocampo C; Zandalazini H; Riccitelli M; Sookoian S; Frider B
    Acta Gastroenterol Latinoam; 1998; 28(4):291-7. PubMed ID: 10347683
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carvedilol, a new nonselective beta-blocker with intrinsic anti- Alpha1-adrenergic activity, has a greater portal hypotensive effect than propranolol in patients with cirrhosis.
    Bañares R; Moitinho E; Piqueras B; Casado M; García-Pagán JC; de Diego A; Bosch J
    Hepatology; 1999 Jul; 30(1):79-83. PubMed ID: 10385642
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between the degree of portal hypertension and the onset of spontaneous bacterial peritonitis in patients with cirrhosis.
    Sersté T; Bourgeois N; Lebrec D; Evrard S; Devière J; Le Moine O
    Acta Gastroenterol Belg; 2006; 69(4):355-60. PubMed ID: 17343075
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.